Diabetes clinical studies groups announced
Clinical groups which will unite leading thinkers in key research areas of diabetes have been developed.
Diabetes UK say the Clinical Studies Groups (CSG) for diabetes aim to have a significant long-term impact on the quality of clinical diabetes research applications in the UK, as they have had for research into other health conditions.
Groups will come together to create a “roadmap for new research by identifying priority areas and the key clinical studies needed to move care forward”, the charity said.
This network of CSGs has been established to facilitate the best collaborative clinical research in diabetes.
The aims of the groups are to generate a portfolio of clinical studies where more evidence is clearly needed, and identify the studies that can, and should, be undertaken.
The groups bring together researchers, healthcare professionals, people living with diabetes to identify research gaps and priorities in each specialty CSG area.
Dr Elizabeth Robertson director of research at Diabetes UK, said: “This is a really important moment in diabetes research and a world first for the community. We believe that bringing together the brightest and best – including those at the front line of both treating and living with diabetes – will help us find the gaps in diabetes research that we need to address. If we work together, we can make sure research moves faster to improve the lives of people with diabetes.”
Lis Warren, who has type 1 diabetes, has been recruited to join the Clinical Studies Group.
She said: “I’m very excited to have this opportunity to look at what more needs to be done to help patients achieve improved management of their diabetes. I have taken part in lots of trials and am aware that many people are not routinely made aware of the trials that exist.
“There are lists available and I’d urge clinicians to encourage their patients to volunteer – especially for International Clinical Trials Day on 20 May. Taking part in research studies supports learning, provides motivation to take care of your diabetes, plus it’s often good fun because you meet other people and get great clinical and peer support.”
It is expected the chairs and the members of the CSGs will give consideration to the remit once the group has been formed and identify, in collaboration with the management committee, where sub-groups may be required. It is expected that the CSGs may evolve over time to reflect the changing face of diabetes research.
Each section has a chair, who has been chosen because of their wealth of experience in their subject.
They are as follows:
CSG 1: Causes of diabetes
Chair: Professor Rebecca Reynolds, University of Edinburgh
CSG 2: Prevention, Targets & Therapies for Type 1 diabetes
Chair: Professor Colin Dayan, Cardiff University
CSG 3: Prevention, Targets & Therapies for Type 2 diabetes
Chair: Dr Rob Andrews, University of Exeter
CSG 4: Acute care
Chair: Dr Gerry Rayman, Ipswich Hospital NHS Trust
CSG 5: Long-term Self-management / Glycemic control
Chair: Dr Mark Evans, University of Cambridge
CSG 6: Microvascular & Microvascular Complications
Chair: Professor John Petrie, University of Glasgow
CSG 7: NIHR CRN: Children/BSPED Diabetes and Endocrinology
Chair: Professor Timothy Barrett, University of Birmingham